| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 10.086 | 51.965 | 130.972 | 95.036 | 8.933 | 7.905 |
| Total Income - EUR | - | - | - | - | 10.086 | 57.174 | 150.861 | 96.016 | 14.639 | 7.905 |
| Total Expenses - EUR | - | - | - | - | 18.333 | 49.739 | 90.284 | 53.542 | 13.049 | 2.427 |
| Gross Profit/Loss - EUR | - | - | - | - | -8.247 | 7.434 | 60.578 | 42.474 | 1.589 | 5.478 |
| Net Profit/Loss - EUR | - | - | - | - | -8.354 | 6.000 | 57.868 | 41.205 | 1.150 | 4.567 |
| Employees | - | - | - | - | 1 | 0 | 1 | 1 | 1 | 0 |
Check the financial reports for the company - Dopamine S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 9.419 | 7.187 | 4.853 | 2.853 | 0 | 0 |
| Current Assets | - | - | - | - | 453 | 4.812 | 60.494 | 79.778 | 86.061 | 86.693 |
| Inventories | - | - | - | - | 341 | 1.944 | 743 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 830 | 59.052 | 61.298 | 76.685 | 77.416 |
| Cash | - | - | - | - | 112 | 2.039 | 700 | 18.481 | 9.376 | 9.277 |
| Shareholders Funds | - | - | - | - | -8.312 | -1.775 | 56.132 | 77.233 | 78.149 | 80.405 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 18.185 | 13.775 | 9.215 | 5.398 | 7.912 | 6.288 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Dopamine S.r.l.